Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 18/20 | 0.44 |
| ▸ | CTSD | P07339 | 7/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | KDM1A | O60341 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2371299 | 0.89 | BACE1 (0.44) | BACE1CTSDKCNH2 | |
| SCHEMBL2371306 | 0.87 | BACE1 (0.59) | BACE1CTSD | |
| SCHEMBL2370438 | 0.80 | BACE1 (0.44) | BACE1CTSDNPC1RAB9AKDM1A | |
| SCHEMBL2371056 | 0.80 | BACE1 (0.62) | BACE1CTSD | |
| SCHEMBL2370580 | 0.79 | BACE1 (0.50) | BACE1CTSDKDM1AKCNH2 | |
| SCHEMBL2522209 | 0.75 | BACE1 (0.65) | BACE1CTSDKCNH2 | |
| SCHEMBL2522204 | 0.75 | BACE1 (0.65) | BACE1CTSDKCNH2 | |
| SCHEMBL2369943 | 0.72 | BACE1 (0.65) | BACE1CTSD | |
| SCHEMBL2370345 | 0.70 | BACE1 (0.51) | BACE1CTSDKCNH2 | |
| SCHEMBL2370817 | 0.69 | BACE1 (0.46) | BACE1CTSDKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2547686-A1 | AMINO -DIHYDROOXAZINE AND AMINO - DIHYDROTHIAZINE SPIRO COMPOUNDS AS BETA - SECRETASE MODULATORS AND THEIR MEDICAL USE | Amgen Inc. (US) | 2013-01-23 | — | — | EP | disclosed |
| WO-2011115928-A1 | AMINO -DIHYDROOXAZINE AND AMINO - DIHYDROTHIAZINE SPIRO COMPOUNDS AS BETA - SECRETASE MODULATORS AND THEIR MEDICAL USE | AMGEN INC. (US) | 2011-09-22 | — | — | WO | disclosed |